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Abstract
Background and Aim: Extracapillary proliferation (crescent) was not included in the Oxford classification, although 
previous attempts to correlate the crescent with clinical outcomes have produced conflicting results. In this study, we 
investigated the clinical and morphological significance of extracapillary proliferation in a group of IgA nephropathy 
(IgAN) patients with regard to the Oxford classification.
Patients and Methods: In an observational study conducted on IgAN patients, we collected a total of 114 biopsies. We 
diagnosed IgAN by light and immunofluorescence for all patients. 
Results: Of the 114 patients, 70.2% were male. The mean age of the patients was 37.7 ± 13.6 years. The mean pro-
teinuria was 1742 ± 1324 mg/day. The mean serum creatinine was 1.6 ± 1.5 mg/dL. Twenty-five (21.9%) patient kidney 
biopsies had extracapillary proliferation. We found a significant positive correlation between the number of crescents 
and serum creatinine (p<0.001). Furthermore, we found a positive association between the nephrotic syndrome and the 
total number of crescents (p<0.05). Additionally, we observed a significant positive correlation between the amount of 
sclerosed glomeruli and extracapillary proliferation (p=0.028). 
Conclusion: Our findings confirm that extracapillary proliferation has a significant association with proteinuria and scle-
rotic glomeruli. We anticipate that extracapillary proliferation will be included in a revision of the Oxford classification 
of IgAN to widen the scope of the classification. Hippokratia 2013; 17 (3): 258-261
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ORIGINAL ARTICLE
Introduction
The International IgA Nephropathy Network developed 
the Oxford classification, which identifies the four mor-
phologic variables with the greatest prognostic importance 
(MEST score)1. These variables include mesangial hypercel-
lularity (M), endocapillary hypercellularity (E), segmental 
glomerulosclerosis (S) and tubular atrophy/interstitial fibro-
sis (T). This classification provides a histopathologic grading 
system that is associated with kidney disease outcomes and 
is independent of clinical features; this classification demon-
strates an improved capacity to predict the outcome of pa-
tients with IgA nephropathy (IgAN)1-3. All four variables of 
the Oxford classification have high reproducibility. However, 
low co-linearity and the lack of clinical factors cause the Ox-
ford classification of IgAN to have some limitations4,5. 
The IgAN is an immune-complex glomerulopathy that 
can result in extracapillary proliferation (crescent)5. Ext-
racapillary proliferation was not included in the Oxford 
classification. However, previous attempts to correlate ex-
tracapillary proliferation with clinical outcomes have pro-
duced conflicting results5,6. IgAN is a highly heterogeneous 
disease with variable clinical patterns, pathologic features, 
long-term renal progression, and geographic prevalence5-
14. The Oxford study comprised a small number of pa-
tients (n=265 patients). Therefore, we feel it is essential to 
conduct complementary studies using a larger number of 
patients from different geographic areas and ethnicities to 
identify important prognostic morphologic variables2,5,8,14. 
Moreover, studies have indicated that extracapillary prolif-
eration is an important factor in IgAN2,3,5. According to the 
results of the Oxford cohort, extracapillary proliferation 
was not associated with kidney disease outcome. How-
ever, recent studies have demonstrated that extracapillary 
proliferation had prognostic significance5,15,16. Thus, it is 
important to re-evaluate crescents in IgAN patients. In our 
study, we investigated the clinical and morphological sig-
nificance of extracapillary proliferation in a group of IgAN 
patients with regard to the Oxford classification.
Patients and Methods
We performed this study based on the Oxford clas-
sification of IgAN after it was published in July 2009 this 
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classification1,17.
Definition of IgAN
The pathologic diagnosis of IgAN requires the obser-
vation of IgA-dominant mesangial or mesangial-capillary 
immune deposits through immunofluorescence (IF) micro-
scopy because this technique can confirm the absence of 
C1q deposits. The immune deposits were semi-quantified 
from 0 to 3+ positive bright. The definition of IgAN re-
quires the presence of diffuse and global IgA deposits of 
grade ≥2+ and the absence of C1q deposition
1,3,17. All renal 
biopsies were performed at private or university medi-
cal centers in Isfahan, Iran, from July 2009 to July 2012; 
these biopsy specimens were sent to a reference laboratory. 
None of the patients underwent treatment before the bi-
opsy. Those biopsies that were less than 8 glomeruli were 
excluded from this study. Based on the questionnaires 
completed at the time of the patients’ admission for biop-
sies, laboratory data in the patients’ records and brief histo-
ries provided by referring physicians, we found no patient 
diagnosed as secondary IgAN and no patient with a history 
of collagen vascular diseases, diabetes or liver cirrhosis. 
 Histologic data
All kidney biopsies were prepared for light and direct 
IF microscopy. The tissues were fixed in 10% formalin for 
histologic sectioning. Each renal biopsy was prepared by 
cutting paraffin blocks into 3-micron thick sections and 
staining 2 slides with periodic acid Schiff, 2 slides with 
hematoxylin and eosin, 1 slide with Jones methenamine 
silver and 1 slide with trichrome. Each slide contained 2 
to 3 sections. Materials used for IF were snap-frozen in 
liquid nitrogen. For the IF study, sections (6 microns thick) 
were stained with fluorescein isothiocyanate-conjugated 
antibodies specific for human IgG, IgM, IgA, C1q, C3 
and fibrin (DAKO, Produktionsvej 42, DK-2600 Glostrup, 
Denmark)18. Our nephropathologist (H.N.) classified the IF 
slides using a brightness scale ranging from 0 to +3. Una-
ware of patients’ data (blind), we performed an IF review 
before we evaluated the slides via light microscopy. After 
an IF diagnosis of IgAN, we reviewed the histopathology 
glass slides to define the morphologic variables, which were 
classified according to the Oxford-MEST method. We also 
assessed the presence of extracapillary proliferation (cellu-
lar, fibrocellular or fibrous crescents). After selecting those 
biopsies that had prominent IgA deposition according to IF 
study and did not meet any exclusion criteria, we classified 
the glass slides according to Oxford-MEST. 
 Definitions of morphologic variables of IgAN and MEST 
(Oxford classification)
We recorded the total number of glomeruli and the 
number of glomeruli with global sclerosis for each bi-
opsy. We estimated the presence of mesangial hypercel-
lularity (M), endocapillary proliferation (E), segmental 
glomerulosclerosis (S) and the proportion of tubular at-
rophy and interstitial fibrosis, IF/TA (T), as defined in the 
Oxford-MEST classification13,8,19.
Definitions of the extracapillary proliferation types 
Extracapillary cell proliferation, or cellular crescent, 
was defined as “more than two cell layers, with >50% of 
the lesion occupied by cells”. Extracapillary fibrocellu-
lar proliferation, or fibrocellular crescent, was defined as 
“extracapillary lesion comprising cells and extracellular 
matrix, with < 50% cells and <90% matrix”. Extracapil-
lary fibrosis, or fibrous crescent, was defined as “>10% 
of the circumference of Bowman’s capsule covered by a 
lesion composed of >90% matrix”1,8. 
Clinical studies and laboratory data
We reviewed the patients’ medical records to obtain var-
ious demographic, clinical and laboratory data at the time of 
their biopsies and for follow-up. We gathered the following 
data at the time of biopsy: race, gender, age, serum creati-
nine and proteinuria (based on a 24-hour urine collection). 
 Statistical analysis
We determined the frequency, mean values and stand-
ard deviations and calculated the statistical significance 
of the differences between the male and female groups 
with regard to crescents using the Mann-Whitney U test. 
We used the Spearman’s correlation coefficient to check the 
correlations. We used a computer program (SPSS version 
16.0, Chicago, IL) for statistical analysis. P<0.05 was 
considered statistically significant.
Results
Population Characteristics
In our observational study, we enrolled a total of 
114 IgAN patient biopsies.
Prevalence
Of the 114 patients, 70.2 % were male. The mean age 
of the patients was 37.7 ± 13.6 years (39.0 ± 14.3 years and 
35.0 ± 11.7 years for male patients and female patients, re-
spectively). The morphologic variables of the Oxford-MEST 
classification are summarized in Table 1. The mean pro-
Histological findings
(Oxford-MEST classification)
Mesangial hypercellularity(number)
M0
M1 
40
73
Endocapillary hypercellularity(number)
E0
E1 
79
35
Segmental glomerulosclerosis(number)
S0
S1 
42
72
Tubular atrophy/interstitial fibrosis(IF/TA) (number)
T0
T1
T2
59
35
20
Table 1:  Histological findings of IgAN patients at the time 
of renal biopsy.
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teinuria was 1742 ± 1324 mg/day (median=1500 mg/day). 
The mean glomeruli number in all renal biopsies was 14.8 
± 7.2. In all biopsies, the mean totally sclerosed glomeruli 
number was 2.4 ± 2.9 (median=1). Also, the mean of serum 
creatinine was 1.6 ± 1.5 mg/dL (median=1.2 mg/dL). Of 
the 114 kidney biopsies, 25 (21.9%) had extracapillary pro-
liferation. Of the 25 IgAN patients who had extracapillary 
proliferation, 13 patients had cellular crescent, 8 patients had 
fibrocellular crescent, and 9 patients had fibrous crescent.
Gender differences
There were no significant differences in total cres-
cents, fibrous crescent, cellular crescent or fibrocellular 
crescent between the male and female subjects (p>0.05).
Correlations
There was a significant positive correlation between 
the number of crescents and serum creatinine (p<0.001). 
Whereas there was a borderline correlation between the 
total crescents and the level of proteinuria (p=0.05), we 
found a significant positive correlation between fibrous 
crescent and proteinuria (p=0.028). Although 11 (9.6%) 
patients had nephrotic-range proteinuria, we found that 
our patients who had a nephrotic syndrome (proteinuria 
>3.5 g/day) had a positive association with total crescents 
(p<0.05). Additionally, there was a significant positive 
correlation between the amount of sclerosed glomeruli 
and extracapillary proliferation (p=0.028). There was 
no positive association between the patients’ age and 
the number of crescents (p>0.05). Except for the nonsig-
nificant association of total crescents with the M variant 
of the Oxford classification (p=0.092), other variants of 
the Oxford classification, including E, S and T morpho-
logic variables, had a significant association with total 
crescents (E: p=0.001; S: p=0.001; and T: p<0.001). A 
study on the association of antibody deposit scores with 
extracapillary proliferation showed a significant positive 
association of IgA score brightness with total crescents 
(r=0.263, p=0.005). There was a significant association 
between C3 scores and the number of crescents (p<0.05). 
There was also a significant positive correlation between 
extracapillary proliferation and tuft-capsule adhesion 
(synechiae) (p=0.003) or thickening of Bowman’s cap-
sule (p=0.001).
Discussion
IgAN is one of the most common primary glomerular 
diseases in the world1-4. Accurately identifying patients 
who are at risk of developing a progressive disease is 
challenging2,3,5. The extent to which histopathologic fea-
tures have prognostic importance is uncertain1-5. Although 
mesangial cell proliferation and matrix expansion are 
common in IgAN, glomerular pathology can also include 
extracapillary proliferation. However, the incidence and 
clinical significance of this lesion are unknown2-5. 
Similar to our finding (21.9% crescents in 114 biop-
sies), in a clinical pathological review of 218 pediatric 
patients, Hogg et al. found that 20% of the patients with 
IgAN had crescents on their initial biopsy specimen20.They 
also found a positive association between the number of 
crescents and endocapillary proliferation. This finding is 
in accordance with our result20. We found a significant 
association between the E variant of the Oxford classi-
fication (endocapillary proliferation) and the number of 
crescents (p=0.001). Walsh et al. conducted a retrospec-
tive analysis of 146 cases with biopsy-proven IgAN. The 
prognostic significance of clinical and histopathologic 
parameters was determined using Cox proportional haz-
ards models. In multivariable models adjusted for clinical 
characteristics, interstitial fibrosis, glomerular sclerosis 
and the number of crescents remained independent pre-
dictors of the primary outcome21. In our study, we found 
a significant positive correlation between extracapillary 
proliferation and the amount of totally sclerosed glomer-
uli, tuft-capsule adhesion (synechiae) or thickening of 
Bowman’s capsule. Totally sclerosed glomeruli, tuft-
capsule adhesion and thickening of Bowman’s capsule 
are chronic lesions that affect the disease outcome22-30. In 
agreement with previous investigators, who have docu-
mented a higher incidence of nephrotic-range proteinuria 
in patients with the crescentic form of IgAN3,5, we found 
a significant positive correlation between fibrous cres-
cent and proteinuria. We also found that the nephrotic 
syndrome had a positive association with total crescents, 
suggesting that patients with this variant of the disease 
may have a worse prognosis. This finding is in accord-
ance with the findings of a study conducted by Nicholls et 
al31. Similarly, Abe et al. studied 205 patients with IgAN 
and found that patients with >25% crescents on initial 
biopsy had <50% renal survival after 4 years32. 
To the best of our knowledge, our work is the first 
study that shows a positive association of the S (segmen-
tal sclerosis) and T (interstitial fibrosis/tubular atrophy) 
variants of the Oxford classification with total crescents. 
We also demonstrated a significant positive association 
between IgA score brightness and the number of cres-
cents. Four variables of the Oxford classification, includ-
ing mesangial hypercellularity, segmental glomeruloscle-
rosis, endocapillary hypercellularity and tubular atrophy/
interstitial fibrosis, have been shown to have independent 
values in predicting renal outcome in the original Oxford 
reports2,3,5,17. However, the significance of the crescents 
was not addressed in the Oxford classification because of 
low prevalence. 
Our study suggests that crescents should be used as an 
important factor in IgAN. To determine which pathologic 
features have prognostic importance for the development 
of end-stage kidney disease in IgAN patients, Katafuchi 
et al, conducted a study on 702 patients with IgAN. The 
association of extracapillary proliferation with kidney 
survival was examined by a univariate analysis in 416 
patients who met the Oxford criteria. In this analysis, 
these authors found that kidney survival was significantly 
lower in patients with extracapillary proliferation than in 
those patients without extracapillary proliferation. They 
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concluded that extracapillary proliferation had prognostic 
significance in their cohort5. In agreement with this find-
ing, Shima et al, analyzed 161 consecutive children with 
newly diagnosed IgA nephropathy from 1977 to 1989. In 
a multivariate analysis, only mesangial hypercellularity 
score, tubular atrophy and the number of crescents were 
significant predictors of renal outcome. These authors 
concluded that although the significance of crescents 
was not addressed in the Oxford classification, crescents 
were important outcome predictors15. Likewise, Kawa-
mura et al. conducted a multicenter case-control study 
on 287 patients with IgAN to develop an evidence-based 
clinicopathologic classification of IgAN for predict-
ing long-term renal outcome. They found that the inde-
pendent pathological variables predicting progression to 
end-stage renal disease were global sclerosis, segmental 
sclerosis and fibrous crescent for early progressors and 
global sclerosis and cellular/fibrocellular crescents for 
late progressors16.
Our findings support the importance of extracapil-
lary proliferation (crescent) due to its association with 
proteinuria and sclerotic glomeruli. We propose that ex-
tracapillary proliferation should be included in the revi-
sion of the Oxford classification of IgAN to widen the 
scope of the classification.
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